» Authors » J T Crawford

J T Crawford

Explore the profile of J T Crawford including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 72
Citations 3612
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Crawford J
Int J Tuberc Lung Dis . 2003 Dec; 7(12 Suppl 3):S453-7. PMID: 14677837
Genotyping of Mycobacterium tuberculosis isolates has been widely used to support investigations of outbreaks and as a tool for studying transmission dynamics and other aspects of tuberculosis epidemiology. Its applications...
2.
Miller A, Butler W, McInnis B, Boutotte J, Etkind S, Sharnprapai S, et al.
Int J Tuberc Lung Dis . 2002 Oct; 6(10):872-8. PMID: 12365573
Setting: An outbreak of tuberculosis caused by Mycobacterium tuberculosis resistant to isoniazid and streptomycin (HS-resistant) was documented in Boston's homeless population in 1984. Isolate relatedness was confirmed at the time...
3.
Braden C, Morlock G, Woodley C, Johnson K, Colombel A, Cave M, et al.
Clin Infect Dis . 2001 Aug; 33(6):e42-7. PMID: 11512106
Drug-susceptible and drug-resistant isolates of Mycobacterium tuberculosis were recovered from 2 patients, 1 with isoniazid-resistant tuberculosis (patient 1) and another with multidrug-resistant tuberculosis (patient 2). An investigation included patient interviews,...
4.
Dale J, Brittain D, Cataldi A, Cousins D, Crawford J, Driscoll J, et al.
Int J Tuberc Lung Dis . 2001 May; 5(3):216-9. PMID: 11326819
Spacer oligonucleotide typing (spoligotyping) is widely used for differentiation of bacteria of the Mycobacterium tuberculosis complex. However, the absence of any standardised method for concise description of spoligotypes makes it...
5.
Steinlein L, Crawford J
J Clin Microbiol . 2001 Mar; 39(3):871-8. PMID: 11230397
We have developed an amplification-based reverse dot blot assay for the detection of specific sites of insertion of the Mycobacterium tuberculosis insertion sequence IS6110. In this assay, a set of...
6.
Hannan M, Desmond E, Morlock G, Mazurek G, Crawford J
J Clin Microbiol . 2001 Feb; 39(2):647-50. PMID: 11158123
Mycobacterium bovis is naturally resistant to the antituberculosis drug pyrazinamide (PZA). To determine whether all Mycobacterium tuberculosis complex isolates demonstrating PZA monoresistance were truly M. bovis, we examined the phenotype...
7.
Morlock G, Plikaytis B, Crawford J
Antimicrob Agents Chemother . 2000 Nov; 44(12):3298-301. PMID: 11083630
Resistance to rifampin in Mycobacterium tuberculosis results from mutations in the gene coding for the beta subunit of RNA polymerase (rpoB). At least 95% of rifampin-resistant isolates have mutations in...
8.
Floyd M, GROSS W, Bonato D, Silcox V, Smithwick R, Metchock B, et al.
Int J Syst Evol Microbiol . 2000 Oct; 50 Pt 5:1811-1816. PMID: 11034491
A previously uncharacterized, slowly growing, scotochromogenic Mycobacterium species was detected by HPLC analysis of the cell-wall-bound mycolic acids. The mycolic acid pattern standard was shown to be a late-eluting, contiguous...
9.
Morlock G, Crawford J, Butler W, Brim S, Sikes D, Mazurek G, et al.
Antimicrob Agents Chemother . 2000 Aug; 44(9):2291-5. PMID: 10952570
We examined the correlation of mutations in the pyrazinamidase (PZase) gene (pncA) with the pyrazinamide (PZA) resistance phenotype with 60 Mycobacterium tuberculosis isolates. PZase activity was determined by the method...
10.
Braden C, Onorato I, Crawford J
JAMA . 2000 Jul; 284(3):305; author reply 306-7. PMID: 10891953
No abstract available.